OPKO Health to Participate in the 40th Annual J.P. Morgan Healthcare Conference
OPKO Health, Inc. (NASDAQ: OPK) announced its participation in the 40th Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
The fireside chat will be webcast live and available for replay in the Investors section of OPKO Health’s website and accessible by clicking here.
About
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220105005859/en/
LHA Investor Relations
ybriggs@lhai.com
or
bvoss@lhai.com
Source: